Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Do

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Cancers|November 11, 2022
Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid CarcinomaGregory Baud, Arnaud Jannin, Camille Marciniak, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 9, 2010
Vascular endothelial growth factor and thymidine phosphorylase expression in salivary gland tumors with distinct metastatic behaviorPaulo Rogério de Faria, Roberto Araújo Lima, Fernando Luiz Dias, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancerHélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
European Journal of Endocrinology|January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF networkMarie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETESégolène Hescot, Véronique Debien, Julien Hadoux, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2018
Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvementSébastien Aubert, Amandine Berdelou, Viviane Gnemmi, et al.
Presse Medicale (Paris, France : 1983)|May 27, 2014
[Malignant insulinoma: recommendations for workup and treatment]Eric Baudin, Philippe Caron, Catherine Lombard-Bohas, et al.
Bulletin Du Cancer|October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Journal of Neuroendocrinology|August 21, 2023
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN networkLucie Duponchelle, Eric Baudin, Fabien Subtil, et al.
Annals of Surgery|March 21, 2018
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE)Bérénice Rault-Petit, Christine Do Cao, Serge Guyétant, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Cancers|November 11, 2022
Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid CarcinomaGregory Baud, Arnaud Jannin, Camille Marciniak, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 9, 2010
Vascular endothelial growth factor and thymidine phosphorylase expression in salivary gland tumors with distinct metastatic behaviorPaulo Rogério de Faria, Roberto Araújo Lima, Fernando Luiz Dias, et al.
Annales D'Endocrinologie|April 27, 2025
ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancerHélène Lasolle, Christine Do Cao, Livia Lamartina, et al.
European Journal of Endocrinology|January 16, 2014
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF networkMarie-Hélène Massicotte, Maryse Brassard, Médéric Claude-Desroches, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETESégolène Hescot, Véronique Debien, Julien Hadoux, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2018
Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvementSébastien Aubert, Amandine Berdelou, Viviane Gnemmi, et al.
Presse Medicale (Paris, France : 1983)|May 27, 2014
[Malignant insulinoma: recommendations for workup and treatment]Eric Baudin, Philippe Caron, Catherine Lombard-Bohas, et al.
Bulletin Du Cancer|October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Journal of Neuroendocrinology|August 21, 2023
Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN networkLucie Duponchelle, Eric Baudin, Fabien Subtil, et al.
Annals of Surgery|March 21, 2018
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE)Bérénice Rault-Petit, Christine Do Cao, Serge Guyétant, et al.
Pageof 12